Insulin glargine (HOE901) - First responsibilities: understanding the data and ensuring safety

被引：11
|
作者：
Buse, J [1 ]
机构：
[1] Univ N Carolina, Diabet Care Ctr, Durham, NC 27713 USA
来源：
DIABETES CARE | 2000年 / 23卷 / 05期
关键词：
D O I：
10.2337/diacare.23.5.576
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：576 / 578
页数：3
相关论文
共 41 条
  • [21] A 16-week comparison of the novel insulin analog insulin glargine (HOE 901) and NPH human insulin used with insulin lispro in patients with type 1 diabetes
    Raskin, P
    Klaff, L
    Bergenstal, R
    Hallé, JP
    Donley, D
    Mecca, T
    DIABETES CARE, 2000, 23 (11) : 1666 - 1671
  • [22] Pharmacokinetics of 125I-labeled insulin glargine (HOE 901) in healthy men -: Comparison with NPH insulin and the influence of different subcutaneous injection sites
    Owens, DR
    Coates, PA
    Luzio, SD
    Tinbergen, JP
    Kurzhals, R
    DIABETES CARE, 2000, 23 (06) : 813 - 819
  • [23] 24h profile of action of biosynthetic long-acting insulin (HOE901) tested in normal volunteers by glucose clamp methodology.
    Soon, PC
    Matthews, DR
    Rosskamp, R
    Herz, M
    Kurzhals, R
    DIABETES, 1997, 46 : 621 - 621
  • [24] A review of the safety and efficacy data for insulin glargine 300 units/ml, a new formulation of insulin glargine
    Dailey, G.
    Lavernia, F.
    DIABETES OBESITY & METABOLISM, 2015, 17 (12): : 1107 - 1114
  • [25] Insulin glargine (HOE 901) lowers fasting blood glucose in children with type I diabetes mellitus without increasing the risk of hypoglycaemia.
    Schoenle, E
    DIABETOLOGIA, 1999, 42 : A235 - A235
  • [26] Insulin glargine 300 U/mL safety data in pregnancy
    Westerbacka, Jukka
    Duverne, Marielle
    Grulovic, Natasa
    Thummisetti, Sreenivas
    Doder, Zoran
    DIABETES OBESITY & METABOLISM, 2025, 27 (05): : 2322 - 2325
  • [27] Efficacy and safety of HOE 901 in patients with type 1 diabetes: A four-week randomised, NPH insulin-controlled trial
    Pieber, T
    Eugene-Jolchine, I
    Derobert, E
    DIABETES, 1998, 47 : A62 - A62
  • [28] Efficacy and safety of HOE 901 in patients with type 1 DM: A four-week randomized, NPH insulin-controlled trial
    Rosenstock, J
    Park, G
    Zimmerman, J
    DIABETES, 1998, 47 : A92 - A92
  • [29] Efficacy and safety of HOE 901 in patients with type 1 diabetes: A four-week randomised, NPH insulin-controlled trial.
    Pieber, TR
    Eugene-Jolchine, I
    Derobert, E
    DIABETOLOGIA, 1998, 41 : A49 - A49
  • [30] Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis
    Bonadonna, Riccardo C.
    Mauricio, Didac
    Mueller-Wieland, Dirk
    Freemantle, Nick
    Bigot, Gregory
    Mauquoi, Celine
    Ciocca, Alice
    Bonnemaire, Mireille
    Gourdy, Pierre
    DIABETES THERAPY, 2021, 12 (04) : 1073 - 1097
12345